Veterinary and Comparative Oncology

Article	Citations
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours	25
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy	22
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma	19
Issue Information	19
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy	18
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma	18
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours	15
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)	15
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy	14
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain	14
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping	14
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs	13
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study	13
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review	13
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study	12
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria	11
Blood biomarkers for canine cancer, from human to veterinary oncology	11
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs	11
Issue Information	10
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma	10
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs	10
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs	9
Cover Image	9
Issue Information	9
Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma	9

Issue Information	9
	9
Corrigendum	9
Author Index	9
	8
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas	8
Expression of Concern: Tumour necrosis factor‐alpha‐induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus	8
	8
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells	8
Immunophenotyping and Mutation Analysis of Canine Intestinal T‐Cell Lymphoma: A Comparative Pathological Study of Human Enteropathy‐Associated T‐Cell Lymphoma	8
Issue Information	8
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs	7
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs	7
Issue Information	7
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain	7
Frontal sinus carcinoma in forty‐one dogs (2001–2022)	7
	7
Issue Information	6
Issue Information	6
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma	6
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma	6
Author Index	6
	6
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma	6
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma	6
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma	6
Issue Information	6
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue	6
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma	6
	6
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry	5
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk	5
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs	5
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells	5
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study	5
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases	5
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study	5
	5
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire	5
Comparison of the anticancer effects of various statins on canine oral melanoma cells	5
Favourable Prognostic Significance of HER2 Mutations in Canine Pulmonary Adenocarcinoma Following Surgical Resection	5
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma	5
Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours	5
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis	5
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance	5
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment	5
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study	5
	5
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs	4
Cyclical 10‐day dosing of melphalan for canine multiple myeloma	4

Correction to “DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue”	4
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study	4
	4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission	4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases	4
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases	4
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience	4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology	4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma	4
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study	4
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy	4
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours	4
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review	4
VCS abstract	4
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases	4
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol	4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours	4
	3
Characterisation of Gene Expression in Canine Invasive Urothelial Carcinoma Using a NanoString‐Based Urine Assay	3
One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas	3
Do Pre‐Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?	3
VCS 2024 Abstracts	3
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes	3
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs	3
Issue Information	3
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma	3
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study	3
Early‐Delayed Radiotoxicity Associated With Stereotactic Radiation Therapy Following a Daily 6 Gy × 5 (30 Gy) Protocol for Presumed Canine Intracranial Meningiomas	3
Correction to: Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	3
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs	3
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma	3
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy	3
Prognostic Impact of a Histologic Grading Scheme in Dogs Diagnosed With Rib Chondrosarcoma	3
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells	3
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour	3
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease	3
Axillary lymphadenectomy in dogs: A description of surgical technique	3
Precision in Parsing: Evaluation of an Open‐Source Named Entity Recognizer (NER) in Veterinary Oncology	3
Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: A Veterinary Society of Surgical Oncology prospective study	3
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade	3
Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours	3
The animal's microbiome and cancer: A translational perspective	3
Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding Pharmacies	2
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration	2
Impacts of Vincristine and Prednisolone Chemotherapy on the Canine Gut Microbiota in Dogs Undergoing Treatment for Lymphoma	2
Neurological Recovery in 14 Cats With Epidural Lymphoma Treated With Chemotherapy	2
Sequence Diversity and Expression Profiles of T Cell Receptor Beta Chain Constant Genes TRBC1 and TRBC2 in Canine Lymphoid Tumour Cell Lines and Normal Lymphocytes	2
Establishment of a new cell line of canine inflammatory mammary cancer: IMC‐118	2
Prognostic Impact of Mast Cell Infiltration Detected by Flow Cytometry on Excised Sentinel Lymph Nodes in Dogs With Newly Diagnosed Mast Cell Tumours	2
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report	2
Author Index	2
Issue Information	2
Outcome and Prognostic Factors of Dogs Treated for Infiltrative Lipoma Undergoing Radiation Therapy: A Retrospective Multi‐Institutional Study of 29 Cases	2
Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma	2
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey	2
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour	2
A multi‐institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma	2
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma	2
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus	2
	2
Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines	2
Issue Information	2
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles	2
Cover Image	2
Issue Information	2
Clinical Utility of Circulating Cell‐Free DNA as a Liquid Biopsy in Cats With Various Tumours	2
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines	2
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours	2
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)	2
Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario‐Based Study	2
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway	2
Issue Information	1
Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma	1
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma	1
Transferrin Receptor‐1: Expression in Canine Mammary Tumours and In Vitro Therapeutic Applications	1
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)	1
Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas	1
	1
Polarisation‐Sensitive Optical Coherence Tomography for Surgical Margin Evaluation and Diagnosis of Excised Canine Cutaneous and Subcutaneous Tumours	1
Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity	1

Impact of palliative‐intent radiotherapy with or without chemotherapy on lameness in flat coat retrievers with localised periarticular histiocytic sarcoma – a retrospective cohort, single institution	1
Multi‐institutional retrospective study of canine foot pad malignant melanomas: 20 cases	1
Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease: or ‘UC or not UC – that is the question’	1
Pilot study to evaluate isolation by size of circulating tumour cells in canine oral melanoma	1
	1
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy	1
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma	1
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study	1
Macrophage Colony Stimulating Factor (M‐CSF) and Interleukin‐34 (IL‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment	1
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine	1
Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	1
Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024)	1
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats	1
Abstracts	1
	1
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs	1
Tolerability Assessment of Orally Administered Paclitaxel With Encequidar in Dogs With Spontaneous Malignancy	1
Evaluating the Impact of Elective Nodal Irradiation for Dogs With Oral Malignant Melanoma Undergoing Hypofractionated Radiotherapy	1
Preoperative Computed Tomography Features as Predictors of Malignancy and Survival in Canine Adrenal Tumours	1
	1
Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer	1
Safety and feasibility of short course pre‐operative radiation therapy followed by surgical excision for canine solid tumours	1
Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases	1
Editorial	1
The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression	1
Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs	1
	1
An aggressive CD4−CD8− T‐cell neoplasm in young English bulldogs	1
Editorial	1
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients	1
Issue Information	1
Issue Information	1
Issue Information	1
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment	1
Investigation of a 4.3 Gy × 10‐Fraction Volumetric Modulated Arc Therapy Protocol for Canine Prostatic Carcinoma: A Normal Tissue Complication Probability Study	1